BRIEF published on 11/19/2024 at 07:08, 1 year 11 months ago Siegfried Opens New R&D Center for Drug Substances in Evionnaz Pharmaceutical Industry Siegfried AG Drug Substances R&D Center Evionnaz
PRESS RELEASE published on 11/19/2024 at 07:03, 1 year 11 months ago Siegfried opens new global R&D Center for Drug Substances in Evionnaz Siegfried inaugurates new R&D Center for Drug Substances in Evionnaz, Switzerland, enhancing global development capabilities and supporting EVOLVE+ strategy Pharmaceutical Industry Drug Substances Siegfried R&D Center Evionnaz
BRIEF published on 11/12/2024 at 06:35, 1 year 11 months ago DINAMIQS s'agrandit avec un nouveau laboratoire à Zurich Thérapie Cellulaire Et Génique Bio-Technopark Zurich Laboratoire DINAMIQS Extension Siegfried Fabrication De Vecteurs Viraux
BRIEF published on 11/12/2024 at 06:35, 1 year 11 months ago DINAMIQS Expands with New Lab in Zurich Cell And Gene Therapy DINAMIQS Lab Siegfried Expansion Viral Vector Manufacturing Bio-Technopark Zurich
PRESS RELEASE published on 11/12/2024 at 06:30, 1 year 11 months ago DINAMIQS opens new lab in Zurich Siegfried's subsidiary DINAMIQS opens new state-of-the-art lab in Zurich Bio-Technopark, strengthening offerings in cell and gene therapy market Cell And Gene Therapy Zurich Siegfried DINAMIQS Lab
BRIEF published on 10/24/2024 at 06:35, 2 years ago Siegfried AG dévoile sa stratégie EVOLVE+ pour une croissance durable Excellence Opérationnelle Développement Stratégique Croissance Pharmaceutique Stratégie EVOLVE+ Agrandissement Du CDMO
BRIEF published on 10/24/2024 at 06:35, 2 years ago Siegfried AG Unveils EVOLVE+ Strategy for Sustained Growth Operational Excellence Strategic Development Pharmaceutical Growth EVOLVE+ Strategy CDMO Expansion
PRESS RELEASE published on 10/24/2024 at 06:30, 2 years ago Strategy EVOLVE+ paves the way for continued profitable growth Siegfried unveils EVOLVE+ strategy at Capital Markets Day, focusing on growth, technology, and operational excellence. CEO emphasizes company's strong position in the CDMO market CDMO Strategy Growth Siegfried EVOLVE+
BRIEF published on 09/04/2024 at 06:35, 2 years 2 months ago EGS Beteiligungen AG augmente sa participation dans Siegfried à 7,2 % des actions nominatives Obligation Convertible Acquisition Pharmaceutique Siegfried Holding EGS Participations AG Augmentation De La Participation
BRIEF published on 09/04/2024 at 06:35, 2 years 2 months ago EGS Beteiligungen AG Increases Stake in Siegfried to 7.2% Registered Shares Convertible Bond Shareholding Increase EGS Beteiligungen AG Pharmaceutical Acquisition Siegfried Holding
Published on 11/06/2026 at 22:15, 12 hours 49 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 22 hours 4 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 22 hours 34 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 22 hours 34 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 14 hours 49 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 14 hours 49 minutes ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 15 hours 49 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 16 hours 4 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 16 hours 32 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 19:06, 15 hours 58 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 16 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 16 hours 3 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 16 hours 4 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
